With the recent rise of virtual and digital methodologies during the global pandemic, experts discuss what the industry can expect for future clinical trial research. As the industry rapidly works to develop vaccines against SARS-CoV-2, more pharmaceutical companies are collaborating and looking for innovative ways to improve clinical trials for the future. A discussion among industry experts, this article explores how leveraging technology, real-time data, and analytics can improve current processes. With the pandemic-related adoption of decentralized clinical trials, technology\u2019s role within clinical trials is expected to grow. Read these experts\u2019 predictions on what sponsors and sites will need to do to meet the everchanging clinical trial needs.